discovered that an oncolytic adenovirus expressing a mutant E300A, lacking p1 binding sites, significantly reduced its ability to inhibit VEGF expression in pancreatic cancer cells (PCCs), leading to increased tumor vascular density. Here, VEGFA is linked to neoplasm.